Literature DB >> 3004209

Dermatomyositis without creatine kinase elevation. A poor prognostic sign.

E J Fudman, T J Schnitzer.   

Abstract

Serum muscle enzyme levels are usually elevated in patients with untreated polymyositis and dermatomyositis. Creatine kinase is the muscle enzyme most often used to diagnose inflammatory myopathies. Seven patients with dermatomyositis and normal creatine kinase levels are described. Five of the seven patients had either an associated malignancy or severe interstitial lung disease. The one-year survival of the six patients followed for that length of time was 33 percent. A lack of creatine kinase elevation in patients with dermatomyositis is a poor prognostic sign.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004209     DOI: 10.1016/0002-9343(86)90036-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

Review 1.  Current management of polymyositis and dermatomyositis.

Authors:  C V Oddis; T A Medsger
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

2.  Dermatomyositis and duodenal carcinoid.

Authors:  Vikas Agarwal; Atul Sachdev; Rajeev Sharma; Rajpal Singh Punia
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

3.  Prognosis and mortality of polymyositis and dermatomyositis patients.

Authors:  A Airio; H Kautiainen; M Hakala
Journal:  Clin Rheumatol       Date:  2006-02-14       Impact factor: 2.980

4.  Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis.

Authors:  Eishi Miyazaki; Masaru Ando; Tomoko Muramatsu; Tetsujiro Fukami; Osamu Matsuno; Shin-Ichi Nureki; Takuya Ueno; Tomiyasu Tsuda; Toshihide Kumamoto
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

5.  Skin rash in a jaundiced patient.

Authors:  M Akasheh; K Omari; F Madanat
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

6.  A case of erythrodermic dermatomyositis associated with gastric cancer.

Authors:  Sung Woo Kim; Yoo Seok Kang; Sang Hoon Park; Un Ha Lee; Hyun Su Park; Sang Jai Jang
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

7.  Cyclosporin for dermatomyositis.

Authors:  S Levi; H J Hodgson
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

8.  Rheumatic diseases and malignancies.

Authors:  Violeta Bojinca; Iustina Janta
Journal:  Maedica (Buchar)       Date:  2012-12

Review 9.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

10.  Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients.

Authors:  E T Koh; A Seow; B Ong; P Ratnagopal; H Tjia; H H Chng
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.